Foresite Capital

Foresite Capital invests across all stages in biotechnology and life sciences, with an emphasis on platform technologies and transformative biopharma. Founder and CEO Jim Tananbaum previously led BioOptions.

$900M (Fund VI, 2024) AUM 71/100 Power Score™ 2011 Founded San Francisco, CA
Healthcare
View Live Interactive Profile → Visit Foresite Capital's Website ↗

Signature Exit

No single defined public exit documented - Foresite invests across biotech and life-sciences platform technologies

Key Partners & Leadership

Jim Tananbaum
Founder & CEO

Firm Timeline

2011
Jim Tananbaum founds Foresite Capital.
2024
Foresite closes Fund VI at approximately $900 million.

Explore Related Firms

More Healthcare firms:

HSGNovo HoldingsDeerfield ManagementVivo Capital
See all Healthcare firms →

More firms in Silicon Valley:

Vivo CapitalAndreessen HorowitzSequoia CapitalTCV
See all Silicon Valley firms →